PrEP Works: The Little Blue Pill That Could
The results are in—pre-exposure prophylaxis (PrEP) works. The strategy, which involves having people take the daily HIV treatment Truvada to prevent becoming infected with HIV, cut transmission on average by up to 73 percent when taken correctly. While experts are celebrating the news, they are also cautioning that the road from research to rollout of PrEP could be long and complicated.
November 11, 2010
AIDSmeds Video: Quest for a Cure On November 3, people living with HIV and their allies gathered in West Hollywood to hear about an exciting new experiment that’s about to get under way. At the meeting, sponsored by the AIDS Policy Project, John Zaia, MD, from the City of Hope in Duarte, California, and Paula Cannon, PhD, from the University of Southern California in Los Angeles, explained the potential behind their new approach to curing AIDS: genetically modifying stem cells taken from people living with both HIV and lymphoma to render their immune systems resistant to HIV.
November 04, 2010
Pam Goodrich: Opening Doors for Prisoners
By 1989, when Pam Goodrich faced the fact that she had HIV, she had been arrested 58 times and had 28 convictions. Today she serves as an education and training coordinator at the LGBT Center in Staten Island, New York—and works as an educator inside Arthur Kill Correctional Facility, a men’s prison on Staten Island. The Pam Goodrich who walks into that prison is very different from the one who did time behind bars. But today’s Goodrich remembers what life was like in the days of prison and drugs. More important, she puts those memories to use, making her an effective advocate for prisoners living with HIV as well as those trying to avoid contracting the virus.
November 02, 2010
Tembeni Fazo: Peer Counseling African Immigrants Living With HIV
Since her HIV-positive diagnosis in 2001, Tembeni Fazo has counseled and educated other African and Caribbean immigrants living with the virus. But her work with the African Services Committee (ASC), a Harlem, New York-based nonprofit organization, also includes reaching out to the community to reduce the stigma and discrimination facing those with HIV/AIDS. Here, Fazo talks about the challenges and rewards of her work—and the hopes she holds for the future of HIV.
November 01, 2010
Jorge Delgado: Ministering to the HIV/AIDS Community
Jorge Delgado felt a calling to become a minister as early as 1980, when he was only 15 years old. In 1986, he was ordained in the Metropolitan Community Church. In 1988, he was diagnosed with HIV and given a life expectancy of one year. Through the years, Delgado has worked with the National Association of People with AIDS, the National Latino AIDS Action Network and the Metropolitan Latino AIDS Coalition. Now, he has returned to his roots in the church, serving as director of HIV/AIDS ministries at the Metropolitan Community Church in the District of Columbia.
More Web Exclusives
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
On November 3, people living with HIV and their allies gathered in West Hollywood to hear about an exciting new experiment that’s about to get under way. At the meeting, sponsored by the AIDS Policy Project, John Zaia, MD, from the City of Hope in Duarte, California, and Paula Cannon, PhD, from the University of Southern California in Los Angeles, explained the potential behind their new approach to curing AIDS: genetically modifying stem cells taken from people living with both HIV and lymphoma to render their immune systems resistant to HIV.
